코크리스탈 파마(COCP)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.12 (+1.82%), 시가총액 $0.02B, 52주 범위 $0.86 ~ $1.94.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment for pandemic and seasonal influenza A; and the inhaled CC-42344 for the potential prophylactic treatment of pandemic and seasonal influenza infections.
코크리스탈 파마의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
코크리스탈 파마의 현재 주가는 $1.12 (+1.82%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
코크리스탈 파마의 시가총액은 약 $0.02B입니다.
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The compan